These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 2513891

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Controlled-release of leuprolide acetate from polylactic acid or copoly(lactic/glycolic) acid microcapsules: influence of molecular weight and copolymer ratio of polymer.
    Ogawa Y, Yamamoto M, Takada S, Okada H, Shimamoto T.
    Chem Pharm Bull (Tokyo); 1988 Apr; 36(4):1502-7. PubMed ID: 3138032
    [No Abstract] [Full Text] [Related]

  • 5. A new biodegradable copolymer of glycolic acid and lactones with relatively low molecular weight prepared by direct copolycondensation in the absence of catalysts.
    Fukuzaki H, Yoshida M, Asano M, Kumakura M, Mashimo T, Yuasa H, Imai K, Yamanaka H, Kawaharada U, Suzuki K.
    J Biomed Mater Res; 1991 Mar; 25(3):315-28. PubMed ID: 2026638
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Hetero-stereocomplexes of D-poly(lactic acid) and the LHRH analogue leuprolide. Application in controlled release.
    Slager J, Domb AJ.
    Eur J Pharm Biopharm; 2004 Nov; 58(3):461-9. PubMed ID: 15451519
    [Abstract] [Full Text] [Related]

  • 10. Biodegradable poly(DL-lactic acid) formulations in a calcitonin delivery system.
    Asano M, Yoshida M, Omichi H, Mashimo T, Okabe K, Yuasa H, Yamanaka H, Morimoto S, Sakakibara H.
    Biomaterials; 1993 Aug; 14(10):797-9. PubMed ID: 8218732
    [Abstract] [Full Text] [Related]

  • 11. A new technique to efficiently entrap leuprolide acetate into microcapsules of polylactic acid or copoly(lactic/glycolic) acid.
    Ogawa Y, Yamamoto M, Okada H, Yashiki T, Shimamoto T.
    Chem Pharm Bull (Tokyo); 1988 Mar; 36(3):1095-103. PubMed ID: 3136939
    [No Abstract] [Full Text] [Related]

  • 12. Prolonged controlled-release of nafarelin, a luteinizing hormone-releasing hormone analogue, from biodegradable polymeric implants: influence of composition and molecular weight of polymer.
    Sanders LM, Kell BA, McRae GI, Whitehead GW.
    J Pharm Sci; 1986 Apr; 75(4):356-60. PubMed ID: 2941563
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Preparation of peroral sustained release drug forms on a base of biodegradable polymers. 1. Preparation and characterization of polylactic acid].
    Mank R, Kala H, Richter M.
    Pharmazie; 1989 Apr; 44(4):276-9. PubMed ID: 2772002
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Anti-luteinizing (LH)-releasing activity of several analogues of LH-releasing hormone.
    Vilchez-Martinez JA, Coy DH, Coy E, Schally AV, Arimura A.
    Fertil Steril; 1975 Jun; 26(6):554-9. PubMed ID: 1093894
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.